Kenneth A Andreoni

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Human CMV-IGIV (CytoGam) neutralizes human cytomegalovirus (HCMV) infectivity and prevents intracellular signal transduction after HCMV exposure
    K A Andreoni
    University of North Carolina at Chapel Hill, USA
    Transpl Infect Dis 3:25-30. 2001
  2. ncbi request reprint Human cytomegalovirus hyperimmune globulin not only neutralizes HCMV infectivity, but also inhibits HCMV-induced intracellular NF-kappaB, Sp1, and PI3-K signaling pathways
    Kenneth A Andreoni
    Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA
    J Med Virol 67:33-40. 2002
  3. ncbi request reprint Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography?
    Kenneth A Andreoni
    Division of Transplantation, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Transplantation 73:1112-6. 2002
  4. ncbi request reprint Laparoscopic incisional hernia repair in liver transplant and other immunosuppressed patients
    Kenneth A Andreoni
    Department of Surgery, The University of North Carolina at Chapel Hill, 27599 7210, USA
    Am J Transplant 2:349-54. 2002
  5. ncbi request reprint Kidney and pancreas transplantation in the United States, 1996-2005
    K A Andreoni
    Surgery, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA
    Am J Transplant 7:1359-75. 2007
  6. ncbi request reprint The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis
    Kui Huang
    Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7155, USA
    Am J Kidney Dis 43:1082-90. 2004
  7. ncbi request reprint Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778
    David L Evers
    Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
    Antiviral Res 65:1-12. 2005
  8. ncbi request reprint Metastatic leiomyosarcoma mimicking polycystic liver disease
    Kimberly L Beavers
    Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7080, USA
    Liver Transpl 8:1192-4. 2002
  9. ncbi request reprint Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
    Leslie P Wong
    Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7155, USA
    Kidney Int 68:362-70. 2005
  10. ncbi request reprint Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
    David J Taber
    Department of Pharmacy, University of North Carolina School of Pharmacy and Medicine, Chapel Hill, NC 27599, USA
    Liver Transpl 8:219-23. 2002

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Human CMV-IGIV (CytoGam) neutralizes human cytomegalovirus (HCMV) infectivity and prevents intracellular signal transduction after HCMV exposure
    K A Andreoni
    University of North Carolina at Chapel Hill, USA
    Transpl Infect Dis 3:25-30. 2001
    ....
  2. ncbi request reprint Human cytomegalovirus hyperimmune globulin not only neutralizes HCMV infectivity, but also inhibits HCMV-induced intracellular NF-kappaB, Sp1, and PI3-K signaling pathways
    Kenneth A Andreoni
    Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA
    J Med Virol 67:33-40. 2002
    ..This suggests that HCMV hyperimmune globulin not only can inhibit viral infectivity, but can also prevent the abnormal cellular signaling that may induce unwanted cellular proliferation or cytokine synthesis...
  3. ncbi request reprint Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography?
    Kenneth A Andreoni
    Division of Transplantation, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Transplantation 73:1112-6. 2002
    ..Although CTA and MRA can detect some proximal moderate to severe arterial changes caused by fibromuscular dysplasia (FMD), mild and distal moderate FMD are not detected well without angiography...
  4. ncbi request reprint Laparoscopic incisional hernia repair in liver transplant and other immunosuppressed patients
    Kenneth A Andreoni
    Department of Surgery, The University of North Carolina at Chapel Hill, 27599 7210, USA
    Am J Transplant 2:349-54. 2002
    ..In our initial series, laparoscopic mesh repair of incisional hernias is practical and safe in the abdominal organ transplant population with a low incidence of early recurrence and serious infections...
  5. ncbi request reprint Kidney and pancreas transplantation in the United States, 1996-2005
    K A Andreoni
    Surgery, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA
    Am J Transplant 7:1359-75. 2007
    ..Pancreas underutilization appears to be an ongoing issue...
  6. ncbi request reprint The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis
    Kui Huang
    Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7155, USA
    Am J Kidney Dis 43:1082-90. 2004
    ....
  7. ncbi request reprint Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778
    David L Evers
    Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
    Antiviral Res 65:1-12. 2005
    ..Our results differ from descriptions of leflunomide acting as an inhibitor of HCMV cytoplasmic capsid formation. Additionally, this study indicates that DHODH may be an effective cellular antiviral target...
  8. ncbi request reprint Metastatic leiomyosarcoma mimicking polycystic liver disease
    Kimberly L Beavers
    Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7080, USA
    Liver Transpl 8:1192-4. 2002
  9. ncbi request reprint Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
    Leslie P Wong
    Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7155, USA
    Kidney Int 68:362-70. 2005
    ..Renal replacement therapy (RRT) is a common bridge to liver transplant despite a paucity of supportive data. We investigated our single-center patient population to determine efficacy of RRT in liver transplant candidates with ARF...
  10. ncbi request reprint Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
    David J Taber
    Department of Pharmacy, University of North Carolina School of Pharmacy and Medicine, Chapel Hill, NC 27599, USA
    Liver Transpl 8:219-23. 2002
    ..1% v 9.2%; P <.01). In conclusion, LRD recipients have significantly decreased tacrolimus dosing requirements compared with CAD recipients during the first 3 months posttransplantation despite having similar tacrolimus concentrations...
  11. doi request reprint The high-risk recipient: the Eighth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium
    Randall S Sung
    Department of Surgery, University of Michigan, Ann Arbor, MI, USA
    Clin Transplant 24:23-8. 2010
    ..These approaches can modify the impact of recipient risk on transplant outcomes and permit transplantation to be applied successfully to a greater variety of patients...
  12. ncbi request reprint Liver transplantation 27 years after bone marrow transplantation from the same living donor
    Kenneth A Andreoni
    N Engl J Med 350:2624-5. 2004
  13. ncbi request reprint Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?
    Peter D Yorgin
    Department of Pediatrics, Section of Pediatric Nephrology, Lucile Salter Packard Children s Hospital, Stanford University, Stanford, CA 94304, USA
    Am J Transplant 2:429-35. 2002
    ..These findings should be interpreted in view of the fact that the newer immunosuppressive agents may have an even more profound effect on anemia and its recovery after transplantation...